Genpact vs Goodrx Holdings
Genpact (G) and Goodrx Holdings (GDRX) side by side: how big they are, what they earn, how their shares have moved and what insiders, members of Congress and funds reported. Figures from filings and closing prices; none of this is a view on either stock.
- Market value
- $6.94B
- Last close
- $41.50
- 12 months
- −5.1%
- Market value
- $996M
- Last close
- $2.92
- 12 months
- +11.4%
At a glance
- The biggest part of Genpact's revenue is High Tech and Manufacturing (39%); at Goodrx Holdings it is Prescription transactions revenue (68%).
- By market value, Genpact ($6.9B) is about 7.0 times Goodrx Holdings ($996M).
- Over the last 12 months Genpact's share price moved −5.1% and Goodrx Holdings's +11.4%; against the S&P 500 that is −10.8 points and +5.7 points.
- In their last fiscal years Genpact kept 10.9% of revenue as net income and Goodrx Holdings 3.8%.
- In the last 90 days insiders reported 0 open-market purchases at Genpact and 0 at Goodrx Holdings; members of Congress disclosed 0 trades in Genpact and 0 in Goodrx Holdings.
- Next results: Genpact Feb 3, 2027, Goodrx Holdings Nov 23, 2026.
How each one makes money: Genpact revenue · Goodrx Holdings revenue
Share prices on one chart
Genpact and Goodrx Holdings, and up to three more you add, drawn on the same scale so you can see which moved more.
Face to face
The figures that separate the two, drawn to the same scale. Every figure is also in the table below.
Size
Market value
Revenue, last fiscal year
Net income, last fiscal year
Every figure
| Genpact GNYSE · Data Processing & Outsourced Services | Goodrx Holdings GDRXNASDAQ · Services-Computer Processing & Data Preparation | |
|---|---|---|
| Size and profitability | ||
| Market value | $6.94B | $996M |
| Revenue, last fiscal year | $5.08B | $797M |
| Net income, last fiscal year | $552M | $30.4M |
| Net marginNet income as a share of revenue | 10.9% | 3.8% |
| Free cash flow | $735M | |
Prices are end-of-day closes, and fundamentals are the companies' last annual figures from their SEC filings: a − or + in the table is a fact of the filing or the close, not a forecast. Market value is the company-level figure at the last close. Counts are of records OQRO holds, by their date; insider history since 2006 comes from the SEC's insider transactions data sets and every filing since. Planned sales under a 10b5-1 plan are counted like other sales.
Common questions
How is Genpact different from Goodrx Holdings?
Genpact (G) is in Data Processing & Outsourced Services on NYSE, with $5.08B of revenue in its last fiscal year and a net margin of 10.9%. Goodrx Holdings (GDRX) is in Services-Computer Processing & Data Preparation on NASDAQ, with $797M of revenue in its last fiscal year and a net margin of 3.8%. The biggest part of Genpact's revenue is High Tech and Manufacturing (39%); at Goodrx Holdings it is Prescription transactions revenue (68%). The table above sets their figures side by side; it compares filings and is not a view on either stock.
How do Genpact and Goodrx Holdings compare in size?
Genpact has the larger market value: Genpact $6.94B and Goodrx Holdings $996M, at the last close.
Whose share price rose more over the last 12 months, G or GDRX?
Over the last 12 months Genpact moved −5.1% and Goodrx Holdings +11.4%. Past price moves say nothing about the future.
Which has had more insider buying, Genpact or Goodrx Holdings?
Since 2006, Goodrx Holdings insiders reported 44 open-market purchases against 13 for Genpact. These are counts of what was filed, not a view on either stock.
Do members of Congress trade G or GDRX?
In the last 12 months, members of Congress disclosed 0 trades in Genpact (G) and 0 in Goodrx Holdings (GDRX).
When did insiders last buy G and GDRX?
See the record behind any of these
A free account opens the full history of every insider and company since 2006, the screener, alerts, Congress trades and fund moves.
Genpact pageGoodrx Holdings pageRare insider trades this weekAll comparisons
https://oqro.io/compare/g-vs-gdrx

